Demythologizing The High Costs Of Pharmaceutical Research

ADHERELY DEMYTHOLOGIZING THE HIGH COSTS OF PHARMACEUTICAL RESEARCH LET'S DO THE MATH INDUSTRY COSTS $802 MILLION $1.32 BILLION $2.16 BILLION 2000 2006 2012 THE ARTIFICIAL FACT ECOM COMPAVES THE PUBLK. POOINS FD A BIG NEWS "WE NEED YOUR MONEY FOR RED" THEY TELL US THAT RED REQUIRES HIGH PRICES COMPANIES TIGHTLY CONTROL ACCESS TO VERIFIABLE FACTS ABOUT THEIR RISKS AND COSTS, ALLOWING ACCESS ONLY TO SUPPORTED ECONOMISTS AT CONSULTING FIRMS AND UNIVERSITIES 2000 RED COSTS STUDY : $802 MILLICON In 24 US COMPANIES INVITED 12 US COMPANIES ACCEPTED 10 US COMPANIES PROVIDED DATA DID NOT ACCOUNT FOR THERAPEUTIC CLASSES. NO ADJUSTMENT FOR TAX-PAYER SUBSIDIES OR DEDUCTIONS. ADDED COSTS OF RETURNS FROM FUNDS THAT WOULD HAVE BEEN INVESTED IN THE STOCK MARKET WERE THE RED PROJECT NOT UNDERTAKEN. THE COSTS REPORTED WERE NOT VERIFIED. WHAT COSTS ARE THEY REPORTING? BUILDINGS AND ROMINISTRATION PATENTS DEVELOPING FOR NEW FOR DOCTORS PROMOTION THAT SOFTWARE LIKE JOURNALS MEDICAL JOURNAL COSTS OF DISCOVERY FOR RECENT BREAKTHROUGH DRUGS, RESEARCH SHOWS THAT: KEY COMPANIES SPENT $2 BILLION US GOVERNMENT SPENT $10 BILLION WAIT THERE'S MORE! EVIDENCE ALSO SUGGESTS THAT THE ESTIMATED COSTS PER TRIAL ARE INFLATED TIME FOR RED ARE ALSO EXAGGERATED COMPANY FINANCIAL RISKS ARE ALSO MUCH LOWER THAN CLAIMED AS RISKS ARE SPREAD OVER MULTIPLE PROJECTS WHY NOT OPEN SOURCE THE DATA? COSTS MLLIONS WHY NOT OF RED PROMISES TO SAVE MORE LIVES OPEN SOURCE CLINICAL TRIALS DATA? QUESTIONABLE QUESTIONABLE QUOTED RED COSTS SHOULD BE SUBJECT TO ANALYSIS SUPPORT THE OPEN SOURCING OF CLINICAL TRIALS AT ALLTRIALS.NET wwW.ADHERELY.COM ADHERELY DESIGN BY W W.JESSICADRAWS.COM DATA FROM: HTTP://WWW.PHARMAMY THS.NET/FILES/BIOSOCIETIES_2011_MYTHS_OF_HIGH_DRUG_RESEARCH_COSTS.PDF DRUGS COMPUTERS EQUIPMENT e JOURNALISTS %24 TRIALS CLINICAL TECHNICAL も 今 UPGRADES NEW DRUG SUPPORT FEES PAYED %24 DEFENCE SUPPORT LEGAL %24 ONU FOR LEGAL EXPENSES NOUSTRY LEADERS, %24